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Abstract
Background: Circulating troponin levels are both stable and higher in patients with end-stage renal 
disease, even in the absence of acute coronary syndrome. These patients commonly have underlying 
cardiac problems that frequently cause troponin elevation. The effect of hemodialysis (HD) on troponin 
levels has not been well elucidated. Thus, investigated herein is the relationship between the changes in 
troponin levels along with left ventricular deformation and volume depletion in patients with end-stage 
renal disease.
Methods: Patients included were between 18 and 85 years of age and were receiving hemodialysis for 
at least 6 months. High sensitive cardiac troponin T (hs-cTnT) levels were studied in blood samples 
taken at the beginning and end of HD. Two-dimensional speckle tracking strain imaging was used to 
evaluate myocardial contractility.
Results: Seventy patients (50.7 ± 16.9 years of age, 27 women) were included in study. The mean 
volume of ultrafiltration was 3260 ± 990 mL. A significant increase in circulating hs-cTnT levels 
was observed, as well as a prominent decrease in left ventricular global longitudinal strain (GLS) after 
HD (52.4 ± 40.2 ng/L vs. 66.8 ± 48.5 ng/L, p < 0.001 and 20.1 ± 3.6% vs. 16.8 ± 3.8% p < 0.001, 
respectively). Moreover, ultrafiltration rate and GLS were found as the strongest independent variables 
in relation to the relative increase in hs-cTnT. 
Conclusions: Hemodialysis can cause a significant increase in hsTnT. This can jeopardize the accu-
racy of clinical diagnoses based on hs-TnT measurements. GLS may be used as a determinant of this 
hs-TnT increase. The influence of HD on the cardiovascular system should be kept in mind to prevent 
unnecessary interventions. (Cardiol J XXXX; XX, X: xx–xx)
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Introduction
Troponins (Tn) are structural proteins in-
volved in the regulation of skeletal and cardiac 
muscle contractility and cardiac troponins (cTn) 
are being used as sensitive and specific markers 
of cardiac injury [1]. Recently developed, new 
generation, high-sensitive cardiac troponin (hs-
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cTn) assays [2, 3] made it possible to detect cTn 
levels in lower concentrations and provided faster 
diagnostic information, which resulted in a reduced 
duration of patient hospitalization [4]. However, 
a variety of conditions can cause an increase in 
hs-cTn in the absence of ischemic heart disease 
[1], one of these conditions being, patients with 
end-stage kidney disease who were shown to 
have higher circulating Tn levels compared to 
the normal population [5–12]. In these patients, 
underlying cardiac problems that frequently lead 
to cTn elevation are also common. However, the 
relationship between renal function disorders and 
the cTn increment is still not fully understood. The 
effect of dialysis on cTn levels has also not been 
robustly elucidated. Long-term cTn measurements 
in patients receiving dialysis therapy were shown 
to be higher than reference values without acute 
exacerbations [7, 8, 12, 13]. There are, however, 
few studies examining the acute effect of dialysis 
on cTn levels. Moreover, end-stage renal disease 
increases the likelihood of having concomitant 
heart disease and structural abnormalities such as 
left ventricular (LV) hypertrophy which also causes 
electrocardiographic findings that mimic ischemia. 
Thus, clinicians are obliged to depend on Tn meas-
urements to diagnose acute coronary syndromes. 
In addition, higher ultrafiltration volumes may 
result in myocardial stunning [14–16] and show 
an impact on cTn levels. LV global longitudinal 
strain (GLS) — a marker of LV systolic function 
— is associated with poor prognosis and has been 
suggested to be a better prognostic indicator than 
conventional LV ejection fraction (EF) in patients 
with chronic kidney disease [17, 18]. Therefore, the 
present study was to investigate (i) the change in 
circulating hs-cTnT levels with hemodialysis (HD); 
(ii) the relationship between changes in hs-cTnT 
levels and volume depletion and (iii) changes in LV 
deformation as assessed by two-dimensional (2D) 
strain echocardiography with HD.
Methods
Study population
This study had a cohort of 70 patients, who 
were followed up in the Hemodialysis Unit of Gazi 
University Medical School Nephrology Depart-
ment. Patients between 18 and 85 years of age, 
who were receiving systemic bicarbonate HD 
3 times a week for at least 6 months were included. 
Patients with LV systolic dysfunction (< 53%) [19], 
evident coronary artery disease and moderate to 
severe valvular heart disease, atrial fibrillation, 
acute coronary syndrome, infectious and inflam-
matory conditions and pulmonary embolism were 
excluded from the study. This study was approved 
by the local ethical committee. 
Study protocol
Blood samples and echocardiographic acqui-
sitions were obtained by providing 72 h between 
HD sessions in order to achieve higher volume 
changes. Dry weight is targeted for each patient 
during HD sessions. Blood pressure, weight and 
heart rate were measured before and after HD. 
The ultrafiltration volume and rate were recorded. 
Blood samples
Blood samples were collected immediately 
before and after HD. HsTnT levels were measured 
with a high sensitive troponin assay (Elecsys® 
Troponin T hs, Roche Diagnostics) with lower de-
tection and upper reference (99th percentile) limits 
of 3 ng/L and 14 ng/L, respectively.
Echocardiography
All images were acquired and measurements 
were performed by an experienced sonographer 
(SÜ) with a GE Vivid 7 Dimension ultrasonogra-
phy machine (GE Vingmed Ultrasound, Horten, 
Norway) equipped with a 3.5 MHz transducer, 
immediately before and after HD. Electrocardio-
gram and respiration of patients were monitored. 
Echocardiographic images with at least three 
cardiac cycles were recorded at the end of expira-
tion. The images were then transferred to a ven- 
dor-specific workstation and analysed with 
EchoPAC, BT 13 (GE Vingmed Ultrasound, Hort-
en, Norway) software. All echocardiographic meas-
urements were performed according to recent 
guidelines [19].
LV strain and strain rate analysis
Apical 4-, 3-, 2-chamber views were acquired 
with high frame rate (> 60 fps) for 2D speckle 
tracking strain analysis. To define the region of 
interest, the endocardial surface was identified 
by manually placing at least 15 markings in all 
apical views. End-diastole was indicated by the 
peak of the R-wave on the electrocardiogram. 
Average GLS were measured as the mean of GLS 
from 4-, 3-, 2-chamber apical views. All strain and 
echocardiographic measurements were performed 
by SÜ, who has a long experience with deforma-
tion imaging.
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Statistical analysis
Continuous variables are presented as mean 
± standard deviation and categorical data are 
presented as percentages or frequencies. Kolmog-
orov-Smirnov was used to check for normality of 
distribution for continuous variables. The paired 
t-test and Wilcoxon test were used to compare 
parametric and nonparametric continuous vari-
ables, respectively, before and after HD. Categori-
cal variables were compared by the c2 test. The 
Pearson correlation test was used to evaluate the 
relationship among changes in hs-cTnT levels, 
GLS and fluid volume withdrawal. Univariate lin-
ear regression analysis with conventional clinical 
variables (age, gender etc.) and contributors with 
a significant correlation were entered in a multi-
ple linear regression model. Possible collinearity 
was checked by using a tolerance and variance 
inflation factor. Variables with a tolerance of less 
than 0.10 and a variance inflation factor of 10 and 
above were withdrawn from the multivariate linear 
regression model. A two-tailed p-value of < 0.05 
was considered as statistically significant. All data 
were analysed with SPSS v.23.0.
Results
Among 80 patients screened, 70 of them 
were included in this study. Seven patients were 
excluded because of newly diagnosed LV systolic 
dysfunction, it was not possible to collect blood 
samples after HD in 3 patients. The baseline char-
acteristics of participants are presented in Table 1. 
A decrease in both systolic and diastolic blood 
pressures and an increase in heart rate after HD 
was observed. However, no significant tachycardia 
(> 100 bpm) was detected after HD, except in 
3 patients. The mean volume of ultrafiltration was 
3260 ± 990 mL. Comparison of clinical vital signs 
before and after HD is shown in Table 2.
A significant increase in serum hs-cTnT levels 
after HD was observed (52.4 ± 40.2 ng/L vs. 66.8 
± 48.5 ng/L, p < 0.001; Fig. 1). A relative change 
in hs-cTnT and ultrafiltration rate showed a sig-
nificant correlation (Fig. 2). 
The size of LV and left atrium decreased 
after HD, whereas LV EF remained unchanged. 
LV GLS also notably decreased after HD. Data of 
echocardiographic parameters are listed in Table 3. 
The relative change in GLS showed strong correla-
tions with relative change in hs-cTnT (Fig. 3) and 
ultrafiltrated volume (Fig. 4). 
In a linear regression analyses, relative change 
in GLS, ultrafiltration rate ultrafiltrated volume, 
and relative change in heart rate were significantly 
correlated with the relative change in hs-cTnT. Ul-
trafiltrated volume was removed from multivariate 
analysis since a high collinearity was found with 
ultrafiltration rate. Multivariate linear regression 
analysis revealed that the ultrafiltration rate and 
the relative change of LV GLS were the strongest 
independent variables associated with an increase 
in hs-cTnT levels (Table 4).
Discussion
In this study, the acute impact of HD on hs-
cTnT levels were investigated. The main findings 
can be summarized as follows: (i) hs-cTnT levels 
Table 1. Baseline characteristics of the participants.
Parameters Mean/Frequency 
(n = 81)
Age [year] 50.7 ± 16.9
Gender (male)  43 (61.4%)
BMI [kg/m2] 23.5 ± 4.4
Duration of HD [month] 78.2 ± 58.7
Ultra-filtrated volume [mL] 3260 ± 990
Ultrafiltration rate [mL/kg/h] 11.6 ± 3.0
Hypertension 27 (33.3%)
Hyperlipidemia 24 (29.6%)
Diabetes mellitus 14 (17.2%)
Glomerulonephritis 10 (12.3%)
Other 13 (16.1%)
Primary unknown renal failure 7 (8.6%)
BMI — body mass index; HD — hemodialysis; Other — polycystic 
kidney disease, amyloidosis, nephrolithiasis, vesicoureteral reflux, 
pyelonephritis, autoimmune diseases, toxic nephropathy
Table 2. Vital clinical parameters before and after hemodialysis (HD). 
Parameters Before HD After HD P
Systolic blood pressure [mmHg] 123.3 ± 21.7 104.2 ± 21.6 < 0.001
Diastolic blood pressure [mmHg] 74.4 ± 12.9 62.6 ± 13.1 < 0.001
Heart rate [bpm] 78  ± 15 86 ± 16 < 0.001
Weight [kg] 70.4 ± 17.6 66.6 ± 15.2 < 0.001
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Table 3. Echocardiographic measurements before and after hemodialysis (HD).
Parameters Before HD After HD P
Dimensions. areas and volumes of left heart
LV end-diastolic diameter (cm) 4.4 ± 0.7 4.0 ± 0.8 < 0.001
LV end-diastolic volume (ml) 75.3 ± 22.7 68.5 ± 29.7 < 0.001
LV end-systolic volume [mL] 26 ± 11.2 23.8 ± 17.8 0.401
LV ejection fraction [%] 66.0 ± 11.5 64.2± 10.6 0.071
LA diameter [cm] 5.1 ± 1.4 4.7± 1.4 < 0.001
LA area [cm2] 29.9± 10.6 19.9 ± 10.3 < 0.001
LA volume index [mL/m2] 48.7 ± 16.3 33.4 ± 16.1 < 0.001
Doppler measurements of left ventricle
E [cm/s] 99 ± 24.8 65.5 ± 23.1 < 0.001
A [cm/s] 94 ± 92.1 76.7 ± 26.9 < 0.001
E/A 1.18 ± 0.6 0.92 ± 0.34 < 0.001
Tissue Doppler measurements of left ventricle
E’lateral [cm/s] 11.1 ± 2.8 10.1 ± 2.8 0.001
A’lateral [cm/s] 12.5 ± 4.1 10.2 ± 3.4 < 0.001
S’lateral [cm/s] 11.1 ± 10.2 9.6 ± 2.9 < 0.001
E/E’lateral 8.8 ± 3.8 6.3 ± 2.9 < 0.001
E’septal [cm/s] 10.9 ± 2.5 10.1 ± 2.8  0.001
A’septal [cm/s] 8.8 ± 2 7.9 ± 2.4 < 0.001
S’septal [cm/s] 10 ± 3.6 8 ± 2.6 < 0.001
E/E’septal 9.6 ± 3.7 8.0 ± 2.4 < 0.001
Speckle tracking echocardiography
LV GLS [%] –20.1 ± 3.6 –16.8 ± 3.8 < 0.001
GLS — global longitudinal strain; LA — left atrium; LV — left ventricle
Figure 1. High-sensitive cardiac troponin T (hs-cTnT) 
levels before and after hemodialysis (HD). Comparison 
between mean values before and after HD is presented. 
Significance is indicated on the graph.
Figure 2. Comparison between relative change of high-
sensitive cardiac troponin T (hs-cTnT) (y-axis) and the 
ultrafiltration rate (x-axis). The correlation coefficient (R) 
is indicated. P value is < 0.001. 
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show a statistically significant increase after HD, 
(ii) relative change in hs-cTnT levels shows strong 
correlation with ultrafiltration rate, (iii) LV systolic 
function evaluated by 2D speckle tracking analysis 
deteriorates with high rapid volume depletion, (iv) 
the relative change in GLS and ultrafiltration rate 
are independently associated with a relative hs-
cTnT increase after HD.
Selection of study population
There have been several studies which aimed 
to investigate the impact of HD on cTn levels 
[7, 8, 10–13, 20–23]. According to available re-
search, none of the studies evaluated the relation 
of ultrafıltration rate, deformation indices and 
changes in circulating cTn levels. Therefore, it 
was decided to investigate patients with end-stage 
kidney disease at a time when the highest volume 
change can be achieved. By having 3200 mL of 
average ultrafiltration volume, it was believed 
that this would obtain the highest possible volume 
changes in the literature. In addition, patients 
without significant cardiac diseases, except LV 
hypertrophy, were enrolled to avoid possible effects 
of cardiac pathologies on changes in cTn levels.
Changes in vital signs and  
cardiac function with HD
In the present study, both systolic and dias-
tolic blood pressures decreased after HD, which is 
Figure 3. Comparison between relative change of global 
longitudinal strain (GLS) measurements (y-axis) and rel-
ative change in high-sensitive cardiac troponin T (hs-cT-
nT) (x-axis). The correlation coefficient (R) is indicated. 
P value is < 0.001. 
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Figure 4. Comparison between relative change of global 
longitudinal strain (GLS) measurements (y-axis) and the 
ultrafiltrated volume (x-axis). The correlation coefficient 
(R) is indicated. P value is < 0.001. 
Table 4. Determinants of relative increase in high sensitive troponin T levels after hemodialysis. 
Parameters Univariate Multivariate
r p R2 p
Age [year] –0.200 0.159
0.826
Gender –0.187 0.282
Change in systolic BP 0.386 0.10
Change in diastolic BP 0.248 0.147
Change in heart rate 0.49 0.045
Change in LV GLS 0.70 < 0.0001 0.001
Change in LV EDV 0.350 0.106
Ultrafiltration rate [mL/kg/h] 0.80 < 0.0001 < 0.0001
BP — blood pressure; EDV — end-systolic volume; GLS — global longitudinal strain; LV — left ventricle
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a physiologic and expected response to a loss of 
fluid and modest decrease in afterload. The heart 
rate of subjects studied increased after HD as a phy- 
siologic response to reduced circulating volume.
Impact of HD on circulating hs-cTn levels
In present study, an almost 30% relative in-
crease in hs-cTn levels was found. In available 
literature, conflicting results have been presented 
about cTn change with HD [7, 8, 10–13, 20–22]. The 
current perception is to expect a modest relative 
decrease in circulating cTn levels after HD [13]. 
However, the rate of ultrafiltrated volume could also 
have an impact on cTn change. The current study 
showed that ultrafiltrated volume showed a strong 
correlation with the relative change in hs-cTn levels.
Elevated cTn concentrations after HD may 
reflect increased concentration due to reduced 
clearance with limited residual renal function [24]. 
Recurrent myocardial damage could be a potent 
reason for cTn elevation [15]. Since the present 
population had a mean of almost 7 years for receiv-
ing HD, chronicity of renal replacement therapy 
could have caused cardiac and renal structural 
damage which could lead to a cTn increase in each 
session of HD. Moreover, it has been claimed that 
HD can lead to myocardial stunning especially in 
high ultrafiltration rates which can also lead to 
acute elevation of hs-cTn T levels [14, 25]. Since 
these patients are at greater risk of coronary artery 
disease development, high volume depletion may 
cause reflex tachycardia and ischemia as a result 
of supply-demand mismatch during HD sessions, 
which may contribute to cTn elevation as well as 
LV hypertrophy.
Impact of HD on echocardiographic  
parameters
Although LV and left atrial dimensions, areas 
and volumes were significantly reduced, no sig-
nificant change in LV EF was observed. Since EF 
is a relative measurement, volume change is not 
expected to affect EF measurements in individuals 
with normal systolic function. Nonetheless, there 
are conflicting findings about LV EF change with 
volume depletion evidenced in research literature, 
which could be due to differing sample sizes and 
methodologies of the studies.
Two-dimensional speckle tracking is a method 
developed for functional assessment of LV. 2D 
speckle tracking derived GLS has now emerged as 
a new index of LV function [19, 26]. GLS appears to 
be robust and more sensitive for detection of subtle 
functional changes, providing complementary and 
superior information over conventional LV EF meas-
urements [27, 28]. In the present study, a significant 
reduction in LV GLS by being highly affected from 
volume change was found. Myocardial stunning 
could also lead to a decrease in LV GLS by having an 
impact on myocardial contractility. LV systolic func-
tion evaluated with GLS during and after HD may 
present cardiac systolic dysfunction. Thus patients 
should be closely monitored and clinicians should be 
aware of possible transient, cardiac decompensation, 
considering concomitant hs-cTn elevation.
Clinical perspective of hs-cTnT  
increase after HD
Chest pain is the most common cause of visits 
to emergency department and almost one-quarter 
of these patients are diagnosed with acute coro-
nary syndrome [1, 4]. To exclude acute myocardial 
infarction in patients with acute onset of chest 
pain, 6–12 h of follow-up was needed with older 
generations of cTn assays [4, 29]. It was therefore 
raising a significant burden on the health care 
system and the possibility of developing faster 
diagnostic algorithms would be a great advantage 
[4]. Patients with end stage kidney disease have 
increased circulating cTn levels. In the present 
population cTn levels were shown to be high but 
stable compared to reference values. However, 
conflicting findings are present on the acute effect 
of HD on cTn levels [8, 13, 24, 30]. Nevertheless, 
clinicians must mainly rely on cTn measurements 
since patients with chronic kidney disease also 
have the most cardiovascular risk factors and 
ischemic findings on electrocardiography which 
could be present due to LV hypertrophy. High 
blood pressure, hyperdynamic circulation due to 
arteriovenous shunt, volume overload and increa-
sed pulse pressure can cause myocardial strain and 
result in elevated cTn in this population [14, 15, 
25]. Moreover, recurrent myocardial damage due 
to decreased myocardial blood flow caused by HD 
plays an important role in cardiac remodeling [14, 
16]. Thus, high ultrafiltration rates and volumes 
are especially shown to be associated with myocar-
dial stunning [25]. Herein an almost 30% relative 
increase in hs-cTnT levels with HD and it was 
demonstrated that this increase is highly correlated 
with the ultrafiltration rate. It was also shown that 
high ultrafiltration volumes have a substantial 
impact on systolic function of LV. Relative change 
in LV GLS also showed a very strong correlation 
with the ultrafiltrated rate. Moreover, LV GLS 
was found to be one of the strongest independent 
variables in relation to a relative hs-cTnT increase. 
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Therefore, it can be claimed that the rate of ul-
trafiltration has a substantial impact on hs-cTnT 
change and myocardial contractility which can be 
also related to an hs-cTnT increase. As suggested 
in the recent guidelines [25], ultrafiltration rates 
and volumes should be minimized to suit what is 
best for patients to achieve hemodynamic stabil-
ity and tolerability. Additional HD sessions should 
be considered for patients instead of extensive 
ultrafiltration rates [25]. Patients on HD therapy 
presenting with chest pain must still be managed 
by measuring serial cTn levels, the change in cTn 
may help in clinical decision making as to whether 
it is acute coronary syndrome or not.
Limitations of the study
In this present study it was endeavoured to 
enrol an adequate number of patients to represent 
a population with end-stage kidney disease. There 
was no possibility of telemetric monitoring or ob-
taining electrocardiogram records which may have 
played an additional role on possible causes of cTn 
elevation before and after HD, however it was not 
needed clinically since none of subjects had related 
symptoms. Since patients with coronary artery 
disease were excluded and the present population 
included patients without previous coronary an-
giogram, an inability to evaluate the possible role 
of significant coronary stenosis causing ischemia 
in these patients might have interfered with the 
results. The aim of this study was to investigate the 
acute effects of HD on hs-cTnT levels and its rela-
tion with ultrafiltration rate and therefore, hs-cTnT 
measurements on 12th or 24th h after HD could not 
be presented. Moreover, HD has various effects 
on cardiovascular dynamics, although we found 
ultrafiltration rate and LV GLS as independent 
variables related to a relative increase of hs-cTnT, 
exact mechanisms of this increase in hs-cTnT level 
require further investigation and cannot be quin-
tessentially elucidated with the present findings. 
To avoid possible variability in measurements of 
echocardiographic parameters, a single observer 
(SÜ), who has substantial experience in echocar-
diography and deformation imaging, performed all 
echocardiographic analyses of the image datasets. 
Conclusions
In the present study, it was shown that hs-
cTnT levels show a significant increase after HD 
which can jeopardize the accuracy of clinical diag-
noses based on hs-cTnT measurements. A strong 
correlation was present among relative changes in 
hs-cTnT levels, LV GLS, and ultrafiltration rate. LV 
GLS was found to be one of the strongest independ-
ent variables associated with the relative hs-cTnT 
increase. Rapid volume depletion substantially 
effected myocardial contractility and resulted in 
possible myocardial damage. The rate of ultrafiltra-
tion should be minimized to avoid possible negative 
consequences. Considering the effect of HD with 
high ultrafiltration rate on circulating hs-cTnT 
levels, it could be of use to prevent misdiagnosis.
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